All filters
Slidesets
Use of INSTI in Patients With Comorbidities and Polypharmacy - Marta Boffito, MD, PhD, FRCP
Presented at:
Salvador HIV Clinical Forum 2021
Slidesets
Long-Acting Drugs for Treatment and Prevention - Charles Flexner, MD
Presented at:
Salvador HIV Clinical Forum 2021
Slidesets
Use of INSTIs in Women of Childbearing Age - Isabel Cassetti, MD
Presented at:
Salvador HIV Clinical Forum 2021
Slidesets
Drug Interactions with Herbal Medicines and Supplements in Complex Patients | David Back
Presented at:
Evolving Care and Management of Patients With Multidrug-Resistant HIV | Satellite Symposium at IAS 2021
Slidesets
Managing Multidrug-Resistant Patients in Low and Medium-Income Countries | François Venter
Presented at:
Evolving Care and Management of Patients With Multidrug-Resistant HIV | Satellite Symposium at IAS 2021
Slidesets
Clinical Case Presentation 2 - Katherine Hsu, MD, MPH, FAAP
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Con (Children Should Not Be Prioritized) - Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Case Presentation 1 - Katie Simon, MD
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Development of a Transition Readiness Score for Adolescents Living with Perinatally-Acquired HIV and Transitioning to Adult Care - Brian Zanoni, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Increasing Capacity to Detect Neurocognitive Impairment among Adolescents and Young Adults with Perinatally Acquired HIV in Thailand: Validity of the NeuorScreen Tablet Application - Reuben N. Robbins, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Hospitalisation Rates for Youth Living with Perinatally acquired HIV Transitioning to Adult Care - Sarah Johnson, United Kingdom
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Projecting Life Expectancy for Youth with Non-Perinatally- and Perinatally-Acquired HIV in the United States - Anne Neilan, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Optimizing Antiretroviral Treatment and Viral Suppression for Adolescents and Young People Living with HIV by Implementing Operation Triple Zero (OTZ) in Four States in Nigeria - Franklin Emerenini, Nigeria
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Rapid Antiretroviral NNRTI-Based Initiation among Youth Living with HIV Outcomes in the National Aids Program in Thailand - Sirinya Teeraananchai, Thailand
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
A Costing Analysis of Index-Linked HIV Testing for Children and Adolescents in Zimbabwe - Arthi Vasantharoopan, United Kingdom
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Estimated Prevalence of Prior HIV Diagnosis Among Children Living With HIV in Eswatini, Lesotho, Malawi, Tanzania, Zambia, and Zimbabwe in the Population HIV Incidence Assessments (PHIA) - Chloe A. Teasdale, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Risk Factors for Post-Discharge Mortality Following Hospitalization for Severe Acute Malnutrition in Zimbabwe and Zambia - Mutsa Bwakura-Dangarembizi, Zimbabwe
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Co-Trimoxazole Prophylaxis for Children Born to Mothers With HIV: Predicted Impact of Different Strategies on Mortality Up To the Age of Two Years - Colette Smith, United Kingdom
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Pediatric ARV Optimization in a Real-World Setting: Dolutegravir Transition in Mozambique - Michelle M. Gill, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
There is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania - Jason Bacha, Tanzania
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Growth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi - Gabriela Toledo, United Kingdom
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Increased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed - Kim Anderson, South Africa
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Determinants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho - Appolinaire Tiam, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Key Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium - Andrew Edmonds, United States
Presented at:
International Workshop on HIV Pediatrics 2021